Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Change in Accured Expenses (2019 - 2026)

Biodesix filings provide 8 years of Change in Accured Expenses readings, the most recent being -$2.3 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 20.95% to -$2.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 55.73% increase, with the full-year FY2025 number at $1.9 million, up 13.56% from a year prior.
  • Change in Accured Expenses hit -$2.3 million in Q1 2026 for Biodesix, down from $974000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.3 million in Q2 2023 to a low of -$2.3 million in Q1 2026.
  • Median Change in Accured Expenses over the past 5 years was $486000.0 (2025), compared with a mean of $52470.6.
  • The widest YoY moves for Change in Accured Expenses: up 2897.25% in 2023, down 370.13% in 2023.
  • Biodesix's Change in Accured Expenses stood at -$127000.0 in 2022, then soared by 698.43% to $760000.0 in 2023, then soared by 122.89% to $1.7 million in 2024, then plummeted by 42.5% to $974000.0 in 2025, then crashed by 340.66% to -$2.3 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$2.3 million (Q1 2026), $974000.0 (Q4 2025), and $486000.0 (Q3 2025) per Business Quant data.